Protecting   people   from   pathogens

TRANSFORMING MICROBIAL DIAGNOSTICS

FOR AGRICULTURE, F&B, FMCG, Healthcare, Pharma & WATER INDUSTRY

THE FUTURE OF MICROBIAL DETECTION IS HERE

CONVENTIONAL METHOD

The current or conventional method of microbial detection is fundamentally over a century old and necessitates trained professionals and a dedicated lab to perform the test. But more importantly, this method is dangerously time consuming (may take 1-2 weeks for results) and has real life consequences ranging from product recalls to disease outbreaks and even loss of human lives.

BIOPSIN'S SOLUTION

We are building the next-gen microbial diagnostic solution which is not only easy to use but capable of providing gold-standard detection of microbes in minutes. It will enable industries to detect pathogens in their products almost in real-time and ensure microbial safety of the consumers. We believe that this technology will fundamentally change the way microbial detection is performed today.

BIOPSIN'S TECHNOLOGY WILL FUNDAMENTALLY CHANGE THE WAY MICROBIAL DETECTION IS PERFORMED TODAY ACROSS INDUSTRIES

Agriculture

F&B

FMCG

Healthcare

Pharma

Water

Considering all factors (e.g. species, logistics etc.), the conventional method of microbial detection takes anywhere from 1-2 weeks for result. This delay in microbial detection has serious real-life consequences. For instance, in healthcare, doctors are forced to prescribe broad-spectrum antibiotics as identifying the exact cause of disease takes days to weeks. Undetected pathogens in agricultural crops and animals become a source of infection as well as contamination further along the supply chain. For low shelf-life F&B and FMCG products, the current industry practice is to ship them out without establishing their microbial safety which from time to time leads to product recalls and disease outbreaks. Ensuring the microbial safety of Water as well Pharma products is also critical but can be hampered by delayed microbial detection. About a billion people are suffering each year due to sluggish microbial detection and its annual economic burden is nearing a trillion dollars.

We are building the next-gen microbial diagnostic solution that will enable industries to detect pathogens in their products almost in real-time with the same gold-standard limit of detection as the conventional method. This means industries can ensure the microbial safety before releasing the products and doctors can prescribe the targeted medicine against a disease. Connect with us to find out more about our solution.

EMPOWERED BY

CONTACT US

contact@biopsin.com
 (+65) 9720 9700

FOLLOW US

Copyright © 2018. Biopsin Pte. Ltd. All rights reserved.

Close Menu